NCT05030233

Brief Summary

Randomized cross-over clinical trial to determine the effect of a nurse-administered comforting touch intervention on the biobehavioral stress responses of preterm infants hospitalized in the neonatal intensive care unit.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 23, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 1, 2021

Completed
9 days until next milestone

Study Start

First participant enrolled

September 10, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2022

Completed
27 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 17, 2022

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

February 18, 2025

Completed
Last Updated

February 18, 2025

Status Verified

January 1, 2025

Enrollment Period

7 months

First QC Date

August 23, 2021

Results QC Date

December 12, 2024

Last Update Submit

January 30, 2025

Conditions

Keywords

preterm infantstressnursing caretouch

Outcome Measures

Primary Outcomes (2)

  • Average Heart Rate -- During Intervention

    heart rate in beats per minute will be measured using an external electrocardiogram monitor and averaged over the intervention or control period

    during intervention or control period, approximately 20 minutes

  • Average Heart Rate -- Recovery

    heart rate in beats per minute will be measured using an external electrocardiogram monitor and averaged over the intervention or control period

    recovery, 30 minutes after intervention delivery or control period

Secondary Outcomes (4)

  • Average High-frequency Heart Rate Variability -- During Caregiving Episode

    during caregiving episode that included either the nurse-administered touch intervention or was delivered as standard care, approximately 20 minutes

  • Average High-frequency Heart Rate Variability -- Recovery

    recovery, 30 minutes after caregiving that included either the nurse-administered touch intervention or standard care

  • Average Frequency of Skin Conductance Responses -- During Caregiving Episode

    during caregiving episode, approximately 20 minutes

  • Average Frequency of Skin Conductance Responses -- Recovery

    recovery, 30 minutes after intervention delivery or control period

Study Arms (2)

Nurse-Administered Touch Intervention

EXPERIMENTAL

Preterm infants will receive the nurse-administered touch intervention during one episode of essential nursing care.

Behavioral: Nurse-Administered Touch Intervention

Standard Care

NO INTERVENTION

Preterm infants will receive one episode of essential nursing care delivered as standard care.

Interventions

The nurse-administered touch intervention is a bare-handed, comforting touch intervention administered during an episode of essential nursing care. The bedside nurse will cradle the infant's head with one hand, using the other hand to gently support the infant's lower body and legs in a flexed position. The touches will be administered for 1 minute at the start of the essential care episode, 30 seconds after the diaper change, and 1 minute at the conclusion of the care episode.

Nurse-Administered Touch Intervention

Eligibility Criteria

AgeUp to 10 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Born prematurely between 27 and 30 weeks post-menstrual age.
  • Born to mothers who are English-speaking and able to provide informed consent.
  • No more than 10 days old at the time of enrollment.

You may not qualify if:

  • Diagnosed with Grade III/IV intraventricular hemorrhage or other neurologic abnormality (e.g. seizure disorder) affecting sensory perception or motor function.
  • Diagnosed with a congenital anomaly requiring surgery during the neonatal period.
  • Receiving scheduled steroids or vasopressors.
  • Skin conditions that preclude the attachment of sensors.
  • Diagnosed with Neonatal Abstinence Syndrome or born to mothers with known illicit drug use, except marijuana, during pregnancy.
  • Diagnosed with chromosomal abnormalities.
  • Requiring special isolation with universal gloving for potentially infectious pathogens.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nationwide Children's Hospital

Columbus, Ohio, 43205, United States

Location

MeSH Terms

Conditions

Premature BirthFractures, Stress

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesFractures, BoneWounds and Injuries

Results Point of Contact

Title
Marliese D. Nist
Organization
The Ohio State University College of Nursing

Study Officials

  • Marliese D. Nist, PhD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
The statistician performing the data analysis will be blinded to group.
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: randomized cross-over design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 23, 2021

First Posted

September 1, 2021

Study Start

September 10, 2021

Primary Completion

April 20, 2022

Study Completion

May 17, 2022

Last Updated

February 18, 2025

Results First Posted

February 18, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations